ArticleBiogerontology2026
Pleiotropy and disease interactors: the dual nature of genes linking ageing and ageing-related diseases.
Article in Biogerontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Ageing-related diseases (ARDs) display diverse phenotypes yet share an age-dependent rise in incidence, suggesting mechanistic links with ageing processes. We examined whether ageing-related genes differ systematically from genes associated with multiple ARD clusters. Across 57 ARDs from UK Biobank, network analyses showed that ageing-related genes, although rarely ARD-associated, lie significantly closer to many ARDs through greater-than-chance proximity in protein-protein interaction (PPI) and KEGG networks. Consistent with this network overlap, ageing-related genes tend to occupy intermediate tiers in KEGG signalling cascades and exhibit strong coexpression with disease-associated genes as well as low tissue specificity, supporting that they play regulatory roles across multiple tissues. In contrast, genes associated with multiple ARDs are enriched for immune disorders and tend to have fewer ARD-associated neighbors in PPI networks. Accordingly, genes associated with multiple ARDs also tend to be located in terminal branches of KEGG pathways and show high tissue specificity coupled with weak coexpression with other ARD genes. Lastly, machine learning integration based on gene-disease network topology identified candidate ageing-related genes enriched for intracellular signal transduction and programmed cell death. Altogether, this work reveals two genetic architectures of multi-ARD influence: a cross-tissue regulatory mechanism enriched in ageing-related genes, and a tissue-specific, immune-driven mechanism among pleiotropic disease-related genes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.